Release today, These are cheap shares, we will be at $39 soon
$39 will fall very quickly, but will still be volatile. Next patient count will surprise a lot of people and be much higher than expected.
$39 target was reached quickly, as I predicted. Cross $40 then $50. $60 will fall this year too.
Not until it fills the gap.